ClinicalTrials.gg
CompletedNCT07937319TELE-CICUpdated Nov 16, 2026

Effect of Tele-Nursing on Adherence, Self-Confidence and Quality of Life in Patients Using Clean Intermittent Catheterization

An interventional study of Tele-Nursing Education and Follow-up in Neurogenic Bladder and Clean Intermittent Catheterization, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2026, registered Oct 2026).
Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 14 studies in Urinary Bladder, Neurogenic with a site in Turkey — none open to participants now, none under way, none of them phase 3. Urinary Bladder, Neurogenic · Turkey.

Enrollment
3rd of 10
84 · median 47
Started
2026
with 1 other
No phase
7 of 14
none open now
Registered
14th of 14
by date

Among the 14 studies in Urinary Bladder, Neurogenic with a site in Turkey, this one is the 3rd largest by enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 7 with no phase, and was the 14th registered.

Urinary Bladder, Neurogenic

191 studies on the registry are indexed under Urinary Bladder, Neurogenic; 40 are open to participants now.

Browse Urinary Bladder, Neurogenic studies →

Open to participants now

None of the 14 studies in Urinary Bladder, Neurogenic with a site in Turkey is open now. The open studies under Urinary Bladder, Neurogenic, anywhere →

Who these studies take

Of the 25 Urinary Bladder, Neurogenic studies recruiting now, 11 (44%) set no upper age limit and 9 (36%) stop at 75 or younger; 7 take children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 14 studies in Urinary Bladder, Neurogenic with a site in Turkey as a file.
02

Study summary

The purpose of this study is to find out whether tele-nursing (education and follow-up provided by a nurse by telephone) after hospital discharge improves adherence, self-confidence and quality of life in patients who perform clean intermittent catheterization (CIC).

Clean intermittent catheterization is a method of emptying the bladder at regular intervals with a catheter in people who cannot empty their bladder on their own, such as people with spinal cord injury. After discharge, patients may have difficulty performing catheterization correctly and regularly, which can lead to complications and reduce their quality of life.

Adult patients performing CIC who were about to be discharged from a spinal cord injury rehabilitation clinic in Ankara, Türkiye, were included in the study. All patients received the clinic's routine discharge education. In addition, patients in the intervention group received 10 structured telephone sessions with a nurse during the 8 weeks after discharge. The control group received routine education only. Adherence to catheterization, self-confidence in performing catheterization and catheterization-related quality of life were measured before discharge and 8 weeks after discharge.

Read the detailed description

This quasi-experimental study with a pretest-posttest control group design was conducted between June and September 2026 at the Spinal Cord Injury Rehabilitation Clinic of Ankara Etlik City Hospital, Physical Medicine and Rehabilitation Hospital, Türkiye.

Sample size was calculated using G*Power 3.1.9.7 (effect size 0.19, alpha 0.05, power 0.90), which indicated a minimum of 38 participants per group. Allowing for a 10% dropout rate, a total of 84 patients (42 per group) were planned.

Eligible patients were assigned to the control or intervention group according to recruitment period; no randomization was performed. To prevent interaction and information sharing between groups, data from the control group were collected first, and recruitment of the intervention group began after the control group was completed.

Both groups received the clinic's routine discharge education. In the intervention group, a tele-nursing program was delivered for 8 weeks after discharge: telephone calls were made twice a week during the first two weeks and once a week thereafter, for a total of 10 calls lasting approximately 15-30 minutes each. The education covered 10 structured topics: basic information on catheterization, CIC procedure steps and hand hygiene, common problems and solutions, complications and their management, catheterization frequency and its importance, urine monitoring, adequate fluid intake, nutrition to prevent constipation, performing CIC in different settings and while traveling, and emergency management. All topics were covered with every patient, while the order and duration of the topics were tailored to individual needs. Calls were conducted in accordance with the Roter Interaction Analysis System (RIAS), based on patient-centered communication. Patients were also able to contact the researcher by phone or video call when needed.

Data were collected face-to-face before discharge (pretest) and by telephone 8 weeks after discharge (posttest), using the Patient Descriptive Characteristics Form, the Intermittent Catheterization Adherence Scale (ICAS), the Self-Confident Scale for Clean Intermittent Self-Catheterization (SCSCISC), the Intermittent Self-Catheterization Questionnaire (ISC-Q) and a Feedback Form. Data were analyzed using descriptive statistics, independent and paired t-tests and the chi-square test; effect size was assessed with Hedges' g, and p\<0.05 was considered statistically significant.

03

Conditions studied

  • Neurogenic Bladder
  • Clean Intermittent Catheterization

Keywords

  • Clean Intermittent Catheterization
  • Adherence
  • Self-Confidence
  • Quality of Life
  • Telenursing
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteering to participate in the study
  • Being 18 years of age or older
  • Performing clean intermittent catheterization for at least the last 6 weeks
  • Being literate in Turkish
  • Having a smartphone, internet access and the WhatsApp application
  • Having discharge planned within one week

Exclusion criteria

Exclusion Criteria:

  • Having any condition that may affect decision-making capacity (e.g., dementia, Alzheimer's disease, psychiatric disorders)
  • Being unable to maintain communication during the study period or wishing to withdraw from the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Tele-Nursing Group

    Patients received the clinic's routine discharge education and, in addition, a structured tele-nursing education and follow-up program for 8 weeks after discharge (10 telephone calls: twice a week in the first two weeks and once a week thereafter, each lasting approximately 15-30 minutes).

    Behavioral: Tele-Nursing Education and Follow-up

  • No intervention
    Control Group

    Patients received only the clinic's routine discharge education. No additional intervention was provided by the researcher. Posttest data were collected by telephone 8 weeks after discharge.

Interventions

  • BehavioralTele-Nursing Education and Follow-up

    A nurse-led tele-nursing program delivered by telephone for 8 weeks after discharge, consisting of 10 calls. The education covered 10 structured topics: basic information on catheterization, CIC procedure steps and hand hygiene, common problems and solutions, complications and their management, catheterization frequency, urine monitoring, adequate fluid intake, nutrition to prevent constipation, performing CIC in different settings and while traveling, and emergency management. The order and duration of topics were tailored to individual needs. Calls followed the Roter Interaction Analysis System (RIAS) for patient-centered communication.

06

What researchers measure

Primary outcomes

  1. Percentage of Participants Who Found the Tele-Nursing Program Useful

    Assessed in the intervention group using a researcher-developed Feedback Form. This is not a scored scale; responses are reported as the number and percentage of participants who rated the telephone-based education and follow-up as useful.

    Time frame: 8 weeks after discharge

  2. Self-Confidence in Clean Intermittent Self-Catheterization

    Assessed using the Self-Confident Scale for Clean Intermittent Self-Catheterization (SCSCISC). The scale consists of 16 items rated on a 5-point Likert scale. Higher scores indicate higher self-confidence.

    Time frame: Baseline (before discharge) and 8 weeks after discharge

  3. Catheterization-Related Quality of Life

    Assessed using the Intermittent Self-Catheterization Questionnaire (ISC-Q). The questionnaire consists of 24 items in 4 domains (ease of use, convenience, discreetness and psychological well-being). Domain and total scores range from 0 to 100. Higher scores indicate better quality of life.

    Time frame: Baseline (before discharge) and 8 weeks after discharge

Secondary outcomes

  1. Patient Satisfaction With the Tele-Nursing Program

    Assessed in the intervention group using a researcher-developed 11-item Feedback Form including complications, healthcare visits and evaluations of the tele-nursing program.

    Time frame: 8 weeks after discharge

07

Study locations

1 site
  • Ankara Etlik City Hospital
    Ankara, Keçiören 06010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because participants did not provide consent for their data to be shared with other researchers, and sharing could compromise participant confidentiality. Aggregated results will be reported in publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Sep 2026, 3 months.

Of 48 non-industry interventional studies with no phase under Urinary Bladder, Neurogenic, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 3 months is below that.

Counting every sponsor, half of 52 studies reached it within 32 months; a quarter within 8 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2026
First posted
Nov 16, 2026
StartActual
Jun 1, 2026
Primary completionActual
Sep 30, 2026
CompletionActual
Sep 30, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937319
Responsible party
Nimet Sena kaya (Research Assistant, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Nov 16, 2026
Start date
Jun 1, 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026
Last update
Nov 16, 2026

Study contacts

Tülay Başak, Prof
study director · University of Health science

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion